• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
John Lauerman

Stay informed with John Lauerman’s coverage and analysis.

Don’t toss those expired home COVID test kits. They may still be good after all
HealthDon’t toss those expired home COVID test kits. They may still be good after all
By Lindsey Rupp, John Lauerman and BloombergDecember 15, 2022
A new batch of COVID pills are in focus as daily life reopens. Here’s how the treatments work—and how well
HealthA new batch of COVID pills are in focus as daily life reopens. Here’s how the treatments work—and how well
By Jason Gale, John Lauerman and BloombergFebruary 15, 2022
Catching the common cold can help fend off COVID, study finds
HealthCatching the common cold can help fend off COVID, study finds
By Tim Loh, John Lauerman and BloombergJanuary 10, 2022
Johnson & Johnson shares jump as company follows GE and Toshiba in decision to split business apart
FinanceJohnson & Johnson shares jump as company follows GE and Toshiba in decision to split business apart
By Riley Griffin, John Lauerman and BloombergNovember 12, 2021
Merck COVID-19 pill
HealthMerck says the U.S. will buy 1.4 million doses of its COVID-19 antiviral pill
By John Lauerman and BloombergNovember 9, 2021
FDA advisors unanimously back Johnson & Johnson COVID boosters for people 18 and older
HealthFDA advisors unanimously back Johnson & Johnson COVID boosters for people 18 and older
By John Lauerman and BloombergOctober 15, 2021
What you need to know about severe reactions to COVID vaccines
HealthWhat you need to know about severe reactions to COVID vaccines
By John Lauerman, Jason Gale and BloombergFebruary 15, 2021
COVID vaccine second shot, dose
HealthWhat to know about delaying second COVID vaccine shots as countries grapple with limited supplies
By John Lauerman, Jason Gale and BloombergJanuary 26, 2021
Health Workers Administer Covid-19 Vaccines At Bronx Nursing Home
HealthEverything to know about allergic reactions to COVID vaccines
By John Lauerman and BloombergDecember 31, 2020
Pfizer to supply U.S. with 100 million more vaccine doses
HealthPfizer to supply U.S. with 100 million more vaccine doses
By John Lauerman, Riley Griffin and BloombergDecember 23, 2020
AstraZeneca acquires rare-disease specialist Alexion in $39 billion deal
HealthAstraZeneca acquires rare-disease specialist Alexion in $39 billion deal
By John Lauerman, James Paton and BloombergDecember 13, 2020
Dr. Anthony Fauci Testifies Before Senate On Federal Response To Pandemic
HealthAnthony Fauci tones down earlier criticism of U.K.’s Pfizer vaccine approval
By John Lauerman, Mike Dorning and BloombergDecember 3, 2020
For AstraZeneca’s COVID vaccine, less may be more—and that’s puzzling researchers
HealthFor AstraZeneca’s COVID vaccine, less may be more—and that’s puzzling researchers
By Angelica LaVito, John Lauerman and BloombergNovember 25, 2020
U.S. government secures 100 million doses of Pfizer, BioNTech vaccine for $2 billion
HealthU.S. government secures 100 million doses of Pfizer, BioNTech vaccine for $2 billion
By John Lauerman and BloombergJuly 22, 2020
CHINA-HEALTH-VIRUS
HealthThe earliest coronavirus vaccines may not protect you from getting infected
By John Lauerman, James Paton and BloombergJune 15, 2020
1
  • 1
  • 2
2
Most Popular
Success
Elon Musk on MacKenzie Scott giving away $26 billion of her fortune: 'Sadly,' it makes the world a worse placeplaceholder alt text
By Sydney LakeJune 29, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeJune 27, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our and Privacy Policy |  | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.